Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer

BACKGROUND: Immune checkpoint inhibitors are increasingly used in neoadjuvant therapy for locally advanced gastric cancer. However, the effect of body composition on the efficacy of neoadjuvant therapy has not been reported. METHODS: The computed tomography (CT) images and clinicopathological data o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Guang-Tan, Huang, Jiao-Bao, Lin, Ju-Li, Lin, Jian-Xian, Xie, Jian-Wei, Wang, Jia-Bin, Lu, Jun, Zheng, Chao-Hui, Huang, Chang-Ming, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772614/
https://www.ncbi.nlm.nih.gov/pubmed/36569876
http://dx.doi.org/10.3389/fimmu.2022.1061044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772614/
https://www.ncbi.nlm.nih.gov/pubmed/36569876
http://dx.doi.org/10.3389/fimmu.2022.1061044

Ejemplares similares